Core Viewpoint - *ST Green Kang is divesting its photovoltaic film business by selling 100% equity of three subsidiaries to Jiangxi Raoxin New Energy Materials Co., Ltd. for cash, aiming to protect shareholder interests and improve financial health [1][4]. Group 1: Company Background - *ST Green Kang, originally focused on veterinary drug development and sales, shifted to the photovoltaic film industry in 2022 due to persistent losses in its core business [2]. - The company acquired Green Kang Yushan for 95 million yuan, despite its book value being only 160,350 yuan, indicating a significant overvaluation at the time of purchase [2][4]. Group 2: Financial Performance - The company has faced substantial losses, reporting a net loss of 222 million yuan in 2023, which is expected to increase to 445 million yuan in 2024, totaling over 700 million yuan in losses within two and a half years [4][5]. - As of June 2023, *ST Green Kang's debt-to-asset ratio surged to 105.82%, indicating a state of insolvency [5]. Group 3: Industry Context - The photovoltaic film industry experienced a downturn from 2023 to 2024, with oversupply leading to declining prices for POE, EVA, and EPE films, adversely affecting *ST Green Kang's profitability [5][6]. - The company's subsidiaries reported negative gross margins in 2024, with Green Kang Yushan at -19.28%, Green Kang Haining at -35.96%, and Green Kang New Energy at 0.41% [5]. Group 4: Strategic Implications - By divesting the loss-making photovoltaic film business, *ST Green Kang aims to refocus on its core veterinary products, enhancing its profitability and sustainability [7]. - The exit from the photovoltaic sector reflects a broader trend of companies withdrawing from the industry amid significant adjustments, with several other firms also choosing to leave [7][8].

Core Viewpoint - The recent announcement by *ST Lvkang to "sell three wholly-owned subsidiaries for 0 yuan" has raised concerns from the Shenzhen Stock Exchange, highlighting the company's deepening operational crisis and strategic missteps [1][2]. Group 1: Asset Acquisition and Disposal - In January 2023, *ST Lvkang acquired Lvkang Yushan for 95 million yuan, viewing it as a key step into the photovoltaic film sector. However, less than two years later, this and two other subsidiaries were sold for 0 yuan to an affiliated party, Jiangxi Raoxin New Energy [2]. - The acquisition of Lvkang Yushan was based on a valuation of 95.7 million yuan, despite its book value being only 1.6035 million yuan, indicating a nearly 60-fold premium. The company claimed it had a technological advantage and stable orders as a core supplier for JinkoSolar [2]. - Following the acquisition, Lvkang Yushan reported continuous losses, with a projected loss of 203 million yuan in 2024, leading to a total book value of the three subsidiaries being negative 100 million yuan [2][3]. Group 2: Financial Performance and Strategic Failures - Originally focused on veterinary medicine, *ST Lvkang's performance declined, prompting a high-profile pivot to the photovoltaic film sector in 2023, including a 290 million yuan investment in a new production project [3]. - The company's net profit attributable to shareholders showed a downward trend with losses of 122 million yuan in 2022, 222 million yuan in 2023, and an expected 445 million yuan in 2024, totaling nearly 700 million yuan in losses [3]. - The rapid expansion in the photovoltaic sector led to oversupply, and the company failed to adapt, resulting in negative net assets and a warning of delisting risk [3]. Group 3: Related Party Transactions and Shareholder Impact - The 0 yuan transaction with Raoxin New Energy, controlled by the company's major shareholder, has been interpreted as an asset stripping maneuver to offload burdens and avoid delisting [4]. - Although the company claims that the transaction does not harm minority shareholders, the transfer of significant loss-making assets raises questions about whether it genuinely resolves underlying issues or merely conceals risks off-balance sheet [4]. Group 4: Future Challenges and Lessons - Even after shedding photovoltaic assets, *ST Lvkang faces ongoing challenges, including a shrinking core business, insufficient profitability, and tight cash flow [5]. - The company has warned of risks related to changes in its main business structure and potential underperformance in profitability following the transaction [5]. - The case of *ST Lvkang serves as a cautionary tale for companies considering cross-industry ventures, emphasizing the need for careful assessment of industry cycles and internal capabilities to avoid resource misallocation and financial crises [5].

Core Viewpoint - Green Kang Biochemical Co., Ltd. plans to sell 100% equity of three subsidiaries to Jiangxi Raoxin New Energy Materials Co., Ltd. for a transaction price of 0 yuan, which constitutes a related party transaction [1][2]. Group 1: Transaction Details - The transaction involves the sale of Green Kang (Yushan) Film Material Co., Ltd., Green Kang (Haining) Film Material Co., Ltd., and Green Kang New Energy (Shanghai) Import and Export Trade Co., Ltd. [1] - As of December 31, 2024, the combined book value of the three subsidiaries is -100.05 million yuan, with an assessed value of -20.84 million yuan, resulting in a value increase rate of 79.17% [1][2]. - The assessment methods used include the asset-based approach and income approach for Green Kang Yushan, while only the asset-based approach was used for Green Kang Haining and Green Kang New Energy [1][4]. Group 2: Financial Performance - Green Kang Yushan's revenue for 2024 is projected at 28.52 million yuan, a year-on-year increase of 82.77%, but it is expected to incur a net loss of 20.33 million yuan [2]. - Green Kang Haining is expected to generate revenue of 8.89 million yuan with a net loss of 15.07 million yuan, while Green Kang New Energy is projected to have revenue of 11.64 million yuan and a net loss of 0.35 million yuan [2]. - The assessment agency noted that the subsidiaries are facing intense competition in the photovoltaic film industry, leading to declining product prices and significant uncertainty regarding their future profitability [2]. Group 3: Valuation Adjustments - Revenue forecasts for Green Kang Yushan were adjusted downward due to ongoing challenges, with expected revenue from 2025 to 2029 revised from 17.43 million yuan to 81.99 million yuan [3]. - Following the adjustments, the assessed value for Green Kang Yushan decreased from -12 million yuan to -40 million yuan, and the overall assessed value for the three subsidiaries changed from -18.74 million yuan to -20.84 million yuan [3]. - Despite the valuation adjustments, the transaction price remains at 0 yuan as agreed upon by both parties [3]. Group 4: Compliance with Valuation Methods - The use of only the asset-based approach for Green Kang Haining and Green Kang New Energy was justified due to their loss-making and suspended operational status, making future income predictions challenging [4]. - The assessment agency confirmed that the approach complies with relevant regulations and industry practices, as there are precedents for using a single valuation method in similar transactions [4].

Core Viewpoint - Zhejiang Securities acts as an independent financial advisor for the major asset sale of Green Kang Biochemical Co., Ltd, responding to inquiries from the Shenzhen Stock Exchange regarding the transaction's details and implications [1]. Group 1: Transaction Overview - Green Kang Biochemical plans to sell 100% equity of three subsidiaries, including Green Kang (Yushan) Film Materials Co., Ltd, Green Kang (Haining) Film Materials Co., Ltd, and Green Kang New Energy (Shanghai) Import and Export Trade Co., Ltd, to Jiangxi Raoxin New Energy Materials Co., Ltd for a cash price of 0 yuan [1]. - As of December 31, 2024, the total book value of the three subsidiaries is -100.05 million yuan, with an assessed value of -18.74 million yuan, resulting in an appreciation rate of 81.27% [1]. Group 2: Financial Analysis - The subsidiaries are experiencing negative gross margins due to changes in supply and demand in the photovoltaic industry, leading to indications of long-term asset impairment [2]. - Revenue forecasts for Green Kang Yushan were adjusted from an original projection of 276.93 million yuan in 2025 to 819.99 million yuan due to declining product prices and insufficient financial support [2]. - The assessment method for Green Kang Haining and Green Kang New Energy was based solely on the asset-based approach due to their operational status, aligning with industry practices [2]. Group 3: Historical Context - In January 2023, Green Kang Biochemical acquired 100% equity of Green Kang Yushan amid a booming photovoltaic industry, establishing a dual business model of veterinary products and photovoltaic film products [3]. - Subsequent capital increases of 70 million yuan in June 2023 and 150 million yuan in December 2024 were aimed at supporting operational needs and improving financial conditions [3]. - The verification by Zhejiang Securities supports the rationality and compliance of the major asset sale, safeguarding the interests of the listed company and minority shareholders [3].

Core Viewpoint - A significant acquisition worth 488 million yuan is pushing a well-known private entrepreneur and his son in Changzhou closer to their dream of going public, as they aim to resolve a pressing "bet agreement" and avoid severe financial repercussions [1][7]. Group 1: Acquisition Context - The acquisition is seen as a necessary step to fulfill a "bet agreement" that requires the core company to go public, following a previous withdrawal of an IPO application due to complex agreements and financing commitments [1][7]. - The target company has faced severe financial difficulties, including failed expansion plans and significant profit declines, leading to consecutive years of losses projected for 2023 and 2024 [3][5]. Group 2: Financial Performance and Challenges - The target company's solar film business, once expected to rank among the top three in the industry, now suffers from negative gross margins and low capacity utilization, with several expansion projects stalled or delayed [5][6]. - The financial struggles are attributed to inventory accumulation, plummeting market prices, and underperforming production capacity, resulting in a gross margin drop from nearly double digits to 3.85% in 2022, and further into negative territory in subsequent years [11]. Group 3: Integration and Synergy Potential - The buyer possesses a well-performing peer company, which has shown rapid revenue and profit growth from 2019 to 2021, suggesting potential for operational synergies through integrated production lines and shared sales channels [6][7]. - However, achieving true synergy is complicated by differing product positioning, customer relationships, and cost structures between the two companies, posing a significant challenge for the buyer [7][9]. Group 4: Financial and Operational Risks - The acquisition may serve as a financial remedy to alleviate the buyer's obligations under previous bet agreements, raising concerns about whether the merger is genuinely aimed at industrial integration or merely a financial maneuver to mitigate risks [7][14]. - The integration process will require patience and a realistic operational roadmap, focusing on supply chain optimization, capacity complementarity, and extending product lines into higher value-added areas [12][14]. Group 5: Future Outlook - The success of the acquisition will depend on the next 12 to 24 months of operations, determining whether it can transition from a financial solution to a tangible industrial entity [14]. - Stakeholders will closely monitor the outcomes, with supporters looking for cost improvements and critics focusing on unresolved capacity issues, while the broader market will assess whether the acquisition fulfills the long-held dream of going public or merely shifts financial risks [14].

与此同时，茹正伟和毛曲波被提名为天洋新材第四届董事会董事候选人。茹正伟为百兴集团董事长茹伯兴之子，常州百瑞兴阳企业管理有限公司（简 称"百瑞兴阳"）实控人之一；毛曲波则为百兴集团财务总监、常州百佳年代薄膜科技股份有限公司（简称"百佳年代"）董事。 百瑞兴阳、百佳年代均为百兴集团旗下公司，百佳年代与天洋新材的主营业务均为光伏胶膜。2024年，在光伏胶膜企业出货排名中，百佳年代位居第三， 天洋新材则排名第八位。这起收购是光伏胶膜行业难得的并购案例，茹伯兴、茹正伟父子在一步步整合胶膜业务奔向资本市场。 行业老三收购行业老八 文 | 华夏能源网 随着李哲龙的逐步淡出和百兴集团的进驻，天洋新材(SH:603330)即将完成易主。 华夏能源网&零碳资本论获悉，9月13日，光伏胶膜企业天洋新材发布公告称，因工作调整，李哲龙辞去公司董事长、法定代表人、总经理、董事会下设 专门委员会委员职务，辞职后李哲龙不在公司担任任何职务。 同时辞职的还有冯延昭。他辞去了天洋新材董事、董事会下设专门委员会委员职务。辞职后，冯延昭仍在公司担任人力资源及行政负责人职务。 天洋新材由李哲龙1993年创立，于2017年初在上交所主板上市。公司初始以 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [7] Core Views - The company reported a revenue of 7.959 billion yuan for the first half of 2025, a year-on-year decrease of 26.06%, with a net profit attributable to shareholders of 496 million yuan, down 46.6% year-on-year. In Q2 2025, revenue was 4.334 billion yuan, a year-on-year decrease of 20.36%, but a quarter-on-quarter increase of 19.58%. The net profit for Q2 was 95 million yuan, down 76.75% year-on-year and down 76.41% quarter-on-quarter. The net profit for the first half of the year was better than the performance forecast [2][5] Summary by Sections Business Performance - In the first half of 2025, the sales volume of film products was nearly 1.4 billion square meters, remaining stable year-on-year, with a gross margin of 11%, down 5 percentage points year-on-year due to a decline in film prices compared to last year. In Q2, both sales volume and gross margin are expected to increase quarter-on-quarter, although the gross margin is expected to decline due to a drop in film prices after the domestic rush to install [11] - The sales volume of photosensitive dry film in the first half of 2025 was nearly 90 million square meters, a year-on-year increase of 22%, with corresponding revenue growth of 18% and a gross margin of 25%, remaining stable year-on-year. In Q2, both sales volume and profitability are expected to grow [11] - The sales volume of aluminum-plastic film in the first half of 2025 was 6.66 million square meters, a year-on-year increase of 19%. The company is focusing on the aluminum-plastic film business as part of its functional film materials division. The sales volume of photovoltaic backsheet was 33.7 million square meters, down about 50% year-on-year due to an increase in the proportion of double-glass components, leading to a decrease in demand for backsheets [11] Financial Indicators - As of the end of Q2, the company's asset-liability ratio was 21%, maintaining an excellent level in the industry. The cash and cash equivalents plus trading financial assets were nearly 6 billion yuan, indicating ample cash reserves. The net cash flow from operating activities for the first half of the year was approximately -900 million yuan, mainly due to a timing difference between sales revenue and actual cash receipts [11] - The company expects an increase in film shipments in the second half of the year, with overseas production capacity gradually contributing to revenue. The profitability of film products is expected to recover, and the photosensitive dry film business is anticipated to benefit from the acceleration of AI applications [11] Future Outlook - The company forecasts a net profit attributable to shareholders of 2.3 billion yuan for 2026, corresponding to a price-to-earnings ratio of 18 times, maintaining the "Buy" rating [11]

Investment Rating - The investment rating for the company is "Buy" and is maintained [7] Core Views - The company reported a revenue of 633 million yuan for H1 2025, a year-on-year decline of 57.47%. The net profit attributable to the parent company was -133 million yuan, showing a reduction in losses [2][5] - In Q2 2025, the company achieved a revenue of 318 million yuan, down 48.07% year-on-year but up 0.66% quarter-on-quarter, with a net profit of -76 million yuan, also indicating a reduction in losses [2][5] - The company is experiencing significant challenges in its film business, with expected sales volume declines and increased costs due to depreciation and labor [10] - The automotive business, particularly the PDCLC dimming film, has made substantial progress, securing partnerships with major automotive manufacturers and initiating a production expansion project [10] - Financial risks have been alleviated, with the debt-to-asset ratio dropping below 50% and inventory decreasing by 40% [10] Summary by Sections Financial Performance - For H1 2025, the company reported a revenue of 633 million yuan, a decrease of 57.47% year-on-year, and a net profit of -133 million yuan, indicating a reduction in losses [2][5] - Q2 2025 revenue was 318 million yuan, down 48.07% year-on-year but up 0.66% from the previous quarter, with a net profit of -76 million yuan [2][5] Business Outlook - The film business is expected to face challenges with declining sales volumes and increased costs, while the automotive business is poised for growth with ongoing partnerships and production expansion [10] - The company is optimistic about the profitability recovery in its film business due to rising EVA particle prices and ongoing collaborations with local enterprises in various countries [10]

Investment - The article discusses various investment opportunities in new materials, semiconductors, and renewable energy sectors, highlighting the growing demand and technological advancements in these areas [1][3][4]. Semiconductor - It emphasizes the importance of semiconductor materials such as photolithography, electronic special gases, and silicon wafers, which are critical for the production of advanced electronic devices [1][3]. - The report outlines the trends in third-generation semiconductors, including silicon carbide and gallium nitride, which are expected to drive future growth [1][3]. New Energy - The article covers the advancements in new energy technologies, particularly lithium batteries and solid-state batteries, which are pivotal for electric vehicles and energy storage solutions [1][3]. - It also mentions the significance of hydrogen energy and wind power as part of the broader renewable energy landscape [1][3]. Photovoltaics - The report highlights the growth in the photovoltaic sector, focusing on materials such as solar glass and photovoltaic back sheets, which are essential for solar panel manufacturing [1][3]. New Display Technologies - The article discusses innovations in display technologies, including OLED, MiniLED, and MicroLED, which are transforming consumer electronics and display applications [3]. Fibers and Composite Materials - It addresses the development of advanced fiber materials like carbon fiber and aramid fiber, which are crucial for lightweight and high-strength applications in various industries [3]. Notable Companies - The article lists key players in the materials sector, including ASML, TSMC, and Tesla, emphasizing their roles in driving innovation and market growth [4]. Investment Strategies - The report outlines different investment stages, from seed rounds to pre-IPO, detailing the associated risks and characteristics of companies at each stage, which is essential for potential investors [6].

Group 1 - Minsheng Securities issued a report on September 1, recommending Haiyou New Materials (688680.SH) with a target price of 47.92 yuan [1] - The report highlights that the profitability of the film business is under short-term pressure [1] - The automotive business is expected to become a new growth driver for the company [1]